𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease

✍ Scribed by Mónica Ballesteros; Christelle Ferrá; David Serrano; Montserrat Batlle; Josep María Ribera; José Luis Díez-Martín

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
196 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab treatment for steroid-refract
Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: A case report
✍ Gaël Piton; Fabrice Larosa; Anne Minello; Marie-Claude Becker; Georges Mantion; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Acute graft-versus-host disease (GVHD) following orthotopic liver transplantation is a rare but severe disease with a 75% death rate in adults. Various therapeutic strategies have been proposed for steroid-refractory GVHD, but there is still no consensus. Tumor necrosis factor-alpha is a key inflamm

Intra-arterial methylprednisolone for th
Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease
✍ Laurie A. Milner; Michael W. Becker; Steven H. Bernstein; Lauren Bruckner; Jonat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Staging System and chromosomal abnormalities determined by standard metaphase karyotype and/or fluorescence in situ hybridization (FISH). Treatment-induced adverse events were graded according to the National Cancer Institute common terminology criteria for adverse events (CTCAE) version 4.0. For r

Role of intra-arterial steroid administr
Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease
✍ Arafat Tfayli; George Selby; Feroz Maqbool; Walter Bierbaum; Mehdi Hamadani 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 2 views

## Abstract We report here a case of severe steroid‐refractory gastrointestinal graft‐versus‐host disease treated with intra‐arterial administration of corticosteroids. A 53‐year‐old female with non‐Hodgkin's lymphoma received peripheral blood hematopoietic stem cell transplant from her HLA‐matched

In vivo CAMPATH-1 monoclonal antibodies:
In vivo CAMPATH-1 monoclonal antibodies: A novel mode of therapy for acute graft-versus-host disease
✍ Varadi, Gabor; Or, Reuven; Slavin, Shimon; Nagler, Arnon 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

CHOP, COP plui doxorubicin. ,'According to NCI criteria (Cheson el al. 151). (PD) was registered in one patient. Median time to disease progression for patients in PR or SD was 9 months (range, 1-14 months) (Table I). The results of the prehent study, although based on a small number of patients,